-
October 08, 2012
Israel has had a tumultuous history since its inception back in 1948. Be it the age old conflict between its ...
-
October 04, 2012
Teva Pharmaceutical Industries Ltd (TEVA) recently announced a deal that will expand the company's central nervous ...
-
September 21, 2012
The HealthCare unit of Bayer (BAYRY) announced recently that it has filed an application seeking approval to market ...
-
September 20, 2012
Impax Laboratories, Inc. (IPXL) and Teva Pharmaceuticals USA, Inc., a wholly owned subsidiary of Teva Pharmaceutical ...
-
September 19, 2012
Encouraged by strong second quarter 2012 results, an upbeat guidance and a series of positive subsequent ...
-
September 17, 2012
In a bid to diversify its business and expand its animal health business, the HealthCare unit of Bayer (BAYRY) inked ...
-
September 17, 2012
In a bid to diversify its business into the pet care space, Perrigo Company (PRGO) inked a deal to buy substantially ...
-
September 12, 2012
Shire LLC, a subsidiary of Shire plc (SHPG) recently announced that it has entered into a settlement agreement with ...
-
September 10, 2012
Perrigo Company (PRGO) recently confirmed that it has filed an abbreviated new drug application (ANDA) with the US ...
-
September 04, 2012
Teva Pharmaceutical Industries Ltd. (TEVA) recently received a boost with the company gaining US Food and Drug ...
-
August 21, 2012
Although this has been a solid year for med-tech, some sub-sectors are starting to lag a bit during this late summer ...
-
August 20, 2012
With the reaffirmation of an earlier ruling from the U.S. Court of Appeals for the Federal Circuit, a major ...
-
August 20, 2012
Teva Pharmaceutical Industries Ltd.'s (TEVA) subsidiary, Teva Women's Health, Inc., recently announced the ...
-
August 15, 2012
Myriad Genetics (MYGN) reported EPS of 34 cents for the fourth quarter of fiscal 2012, up 14% year over year and at ...
-
August 14, 2012
Mylan Inc. (MYL) recently announced that it has launched its generic version of Noven Therapeutics' Lithobid ...
-
August 09, 2012
Teva Pharmaceutical Industries Ltd. (TEVA) and Active Biotech recently announced that they intend to commence a ...
-
August 06, 2012
Par Pharmaceutical Companies Inc. (PRX) posted second quarter 2012 adjusted earnings of $1.62 per share, well above ...
-
August 03, 2012
Teva Pharmaceutical Industries' (TEVA) second quarter earnings of $1.28 per American Depositary Share (ADS) were a ...
-
August 02, 2012
Shire plc (SHPG) posted second-quarter 2012 earnings (excluding special items) of $1.68 per American Depositary ...
-
July 12, 2012
Teva Pharmaceutical Industries Ltd. (TEVA) recently announced another favorable decision regarding its Copaxone ...
